782 total citations 11 papers, 591 citations indexed
About
Stephen M. Holliday is a scholar working on Epidemiology, Psychiatry and Mental health and Pharmacology.
According to data from OpenAlex, Stephen M. Holliday has authored 11 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Psychiatry and Mental health and 2 papers in Pharmacology. Recurrent topics in Stephen M. Holliday's work include Pneumonia and Respiratory Infections (2 papers), Hallucinations in medical conditions (1 paper) and Respiratory viral infections research (1 paper). Stephen M. Holliday is often cited by papers focused on Pneumonia and Respiratory Infections (2 papers), Hallucinations in medical conditions (1 paper) and Respiratory viral infections research (1 paper). Stephen M. Holliday collaborates with scholars based in New Zealand. Stephen M. Holliday's co-authors include Paul Benfield, Rex N. Brogden, Katharine J. Palmer, Diana Faulds, Eugene M. Sorkin, Greg L. Plosker and Karen L. Goa and has published in prestigious journals such as Drugs, PharmacoEconomics and Drugs & Aging.
Citations per year, relative to Stephen M. Holliday Stephen M. Holliday (= 1×)
peers
Michel Ollagnier
Countries citing papers authored by Stephen M. Holliday
Since
Specialization
Citations
This map shows the geographic impact of Stephen M. Holliday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Holliday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Holliday more than expected).
Fields of papers citing papers by Stephen M. Holliday
This network shows the impact of papers produced by Stephen M. Holliday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Holliday. The network helps show where Stephen M. Holliday may publish in the future.
Co-authorship network of co-authors of Stephen M. Holliday
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen M. Holliday.
A scholar is included among the top collaborators of Stephen M. Holliday based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Stephen M. Holliday. Stephen M. Holliday is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
11 of 11 papers shown
1.
Holliday, Stephen M. & Paul Benfield. (1998). Meropenem. PharmacoEconomics. 13(3). 359–377.6 indexed citations
2.
Holliday, Stephen M., Paul Benfield, & Greg L. Plosker. (1998). Fosphenytoin. PharmacoEconomics. 14(6). 685–690.9 indexed citations
Holliday, Stephen M. & Paul Benfield. (1997). Interferon-β-1a. BioDrugs. 8(4). 317–330.11 indexed citations
6.
Holliday, Stephen M. & Paul Benfield. (1995). Venlafaxine. Drugs. 49(2). 280–294.242 indexed citations
7.
Holliday, Stephen M. & Diana Faulds. (1994). Hepatitis B Vaccine. PharmacoEconomics. 5(2). 141–171.18 indexed citations
8.
Holliday, Stephen M., Diana Faulds, & Eugene M. Sorkin. (1994). Inhaled Fluticasone Propionate. Drugs. 47(2). 318–331.88 indexed citations
9.
Holliday, Stephen M. & Greg L. Plosker. (1993). Paroxetine. Drugs & Aging. 3(3). 278–299.21 indexed citations
10.
Holliday, Stephen M. & Diana Faulds. (1993). Miocamycin. Drugs. 46(4). 720–745.8 indexed citations
11.
Palmer, Katharine J., Stephen M. Holliday, & Rex N. Brogden. (1993). Mefloquine. Drugs. 45(3). 430–475.186 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.